• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心律失常性心肌病

Arrhythmia induced cardiomyopathy.

作者信息

Sugumar Hariharan, Prabhu Sandeep, Voskoboinik Aleksandr, Kistler Peter M

机构信息

The Baker Heart & Diabetes Institute Melbourne Vic. Australia.

The Alfred Hospital Melbourne Vic. Australia.

出版信息

J Arrhythm. 2018 Jul 20;34(4):376-383. doi: 10.1002/joa3.12094. eCollection 2018 Aug.

DOI:10.1002/joa3.12094
PMID:30167008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6111481/
Abstract

Arrhythmia induced cardiomyopathies (AIC) refer to the collective condition of Arrhythmia, Tachycardia, and ectopy-induced Cardiomyopathy. Atrial fibrillation (AF) and heart failure (HF) are modern epidemics that often coexist and exacerbate one another. We aim to provide an overview of the current understanding and evidence for treatment and management in AIC with a particular focus on AF-mediated cardiomyopathy and suggest approaches to recognize, screen, and manage AIC.

摘要

心律失常性心肌病(AIC)是指由心律失常、心动过速和异位心律引起的心肌病的统称。心房颤动(AF)和心力衰竭(HF)是现代常见疾病,常并存且相互加重。我们旨在概述目前对AIC治疗和管理的认识及证据,特别关注房颤介导的心肌病,并提出识别、筛查和管理AIC的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/6111481/e161daf1c0fa/JOA3-34-376-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/6111481/c9f2f2363f62/JOA3-34-376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/6111481/9b40986e6c2e/JOA3-34-376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/6111481/ff7f32123381/JOA3-34-376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/6111481/e161daf1c0fa/JOA3-34-376-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/6111481/c9f2f2363f62/JOA3-34-376-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/6111481/9b40986e6c2e/JOA3-34-376-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/6111481/ff7f32123381/JOA3-34-376-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f86/6111481/e161daf1c0fa/JOA3-34-376-g004.jpg

相似文献

1
Arrhythmia induced cardiomyopathy.心律失常性心肌病
J Arrhythm. 2018 Jul 20;34(4):376-383. doi: 10.1002/joa3.12094. eCollection 2018 Aug.
2
Mechanisms and Clinical Significance of Arrhythmia-Induced Cardiomyopathy.心律失常性心肌病的发生机制及临床意义。
Can J Cardiol. 2018 Nov;34(11):1449-1460. doi: 10.1016/j.cjca.2018.07.475. Epub 2018 Aug 1.
3
Echocardiographic changes and heart failure hospitalizations following rhythm control for arrhythmia-induced cardiomyopathy: results from a multicenter, retrospective study.心律失常性心肌病行节律控制治疗后的超声心动图改变和心力衰竭住院:一项多中心回顾性研究的结果。
J Interv Card Electrophysiol. 2023 Mar;66(2):455-462. doi: 10.1007/s10840-022-01354-2. Epub 2022 Aug 26.
4
Arrhythmia-Induced Cardiomyopathy: Prevalent, Under-recognized, Reversible.心律失常性心肌病:普遍存在、认识不足、可逆转
J Atr Fibrillation. 2017 Oct 31;10(3):1776. doi: 10.4022/jafib.1776. eCollection 2017 Oct-Nov.
5
Arrhythmia-Induced Cardiomyopathy.心律失常性心肌病。
Dtsch Arztebl Int. 2018 May 11;115(19):335-341. doi: 10.3238/arztebl.2018.0335.
6
Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.心律失常性心肌病:机制、识别与管理
J Am Coll Cardiol. 2015 Oct 13;66(15):1714-28. doi: 10.1016/j.jacc.2015.08.038.
7
Atrial fibrillation and heart failure: A contemporary review of current management approaches.心房颤动与心力衰竭:当前管理方法的当代综述
Heart Rhythm O2. 2021 Dec 17;2(6Part B):762-770. doi: 10.1016/j.hroo.2021.11.006. eCollection 2021 Dec.
8
Catheter ablation for atrial fibrillation in patients with congestive heart failure.心力衰竭患者心房颤动的导管消融。
Int J Cardiol. 2021 Jun 15;333:98-104. doi: 10.1016/j.ijcard.2021.02.060. Epub 2021 Feb 27.
9
Utility of Routine Transthoracic Echocardiographic Parameters to Predict Functional Recovery after Catheter Ablation Therapy in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction.常规经胸超声心动图参数在预测左室收缩功能障碍的房颤患者导管消融治疗后心功能恢复中的作用。
Int Heart J. 2023;64(3):386-393. doi: 10.1536/ihj.22-648.
10
Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy.心力衰竭管理与治疗的新观念:聚焦于心动过速性心肌病
Drugs Context. 2023 Jan 4;12. doi: 10.7573/dic.2022-8-4. eCollection 2023.

引用本文的文献

1
Study of left heart parameters related to recurrence in patients with atrial fibrillation after radiofrequency ablation by ultrasonography.超声心动图对心房颤动患者射频消融术后复发相关左心参数的研究
Medicine (Baltimore). 2025 May 9;104(19):e42349. doi: 10.1097/MD.0000000000042349.
2
[Incessant focal atrial tachycardia as a cause of cardiomyopathy. About a case].[持续性局灶性房性心动过速作为心肌病的病因。病例报告]
Arch Peru Cardiol Cir Cardiovasc. 2021 Jun 30;2(2):141-146. doi: 10.47487/apcyccv.v2i2.135. eCollection 2021 Apr-Jun.
3
[Arrhythmogenic right ventricular cardiomyopathy associated with arrhythmia-induced cardiomyopathy: A case report].

本文引用的文献

1
Catheter Ablation for Atrial Fibrillation with Heart Failure.心力衰竭合并心房颤动的导管消融治疗。
N Engl J Med. 2018 Feb 1;378(5):417-427. doi: 10.1056/NEJMoa1707855.
2
How to perform posterior wall isolation in catheter ablation for atrial fibrillation.如何在房颤导管消融中进行后壁隔离。
J Cardiovasc Electrophysiol. 2018 Feb;29(2):345-352. doi: 10.1111/jce.13397. Epub 2017 Dec 26.
3
Pathophysiology, diagnosis and treatment of tachycardiomyopathy.心动过速性心肌病的病理生理学、诊断与治疗
[致心律失常性右室心肌病合并心律失常性心肌病:一例报告]
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Oct 18;53(5):1002-1006. doi: 10.19723/j.issn.1671-167X.2021.05.032.
4
Miocardiopatía inducida por arritmia: informe de caso.心律失常所致心肌病:病例报告
Arch Cardiol Mex. 2021;91(3):379-382. doi: 10.24875/ACM.200002521.
5
Turkish Society of Cardiology consensus paper on management of arrhythmia-induced cardiomyopathy.土耳其心脏病学会关于心律失常性心肌病管理的共识文件。
Anatol J Cardiol. 2019 Feb;21(2):98-106. doi: 10.14744/AnatolJCardiol.2019.60687.
Heart. 2017 Oct;103(19):1543-1552. doi: 10.1136/heartjnl-2016-310391. Epub 2017 Aug 30.
4
Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study.导管消融与房颤伴收缩功能障碍的药物心率控制:CAMERA-MRI 研究。
J Am Coll Cardiol. 2017 Oct 17;70(16):1949-1961. doi: 10.1016/j.jacc.2017.08.041. Epub 2017 Aug 27.
5
Atrial Fibrillation and Heart Failure - Cause or Effect?心房颤动与心力衰竭——因还是果?
Heart Lung Circ. 2017 Sep;26(9):967-974. doi: 10.1016/j.hlc.2017.05.117. Epub 2017 May 22.
6
Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy.心肌病遗传学的临床与机制见解
J Am Coll Cardiol. 2016 Dec 27;68(25):2871-2886. doi: 10.1016/j.jacc.2016.08.079.
7
Atrioventricular Nodal Non Re-Entrant Tachycardia (AVNNT).房室结非折返性心动过速(AVNNT)。
Heart Lung Circ. 2017 May;26(5):524-525. doi: 10.1016/j.hlc.2016.07.014. Epub 2016 Aug 30.
8
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.导管消融术与胺碘酮治疗心力衰竭伴植入装置患者持续性心房颤动的疗效比较:AATAC多中心随机试验结果
Circulation. 2016 Apr 26;133(17):1637-44. doi: 10.1161/CIRCULATIONAHA.115.019406. Epub 2016 Mar 30.
9
Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.心房颤动引发心力衰竭,反之亦然:射血分数保留与降低时的时间关联及差异
Circulation. 2016 Feb 2;133(5):484-92. doi: 10.1161/CIRCULATIONAHA.115.018614. Epub 2016 Jan 8.
10
Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.心律失常性心肌病:机制、识别与管理
J Am Coll Cardiol. 2015 Oct 13;66(15):1714-28. doi: 10.1016/j.jacc.2015.08.038.